MAPK3 and prostate carcinoma: For instance, Bioinformatic analysis in a study by Hsieh et al. in prostate cancer cells suggested that PLZF negatively regulates the MAPK pathway via repressing ERK1/2 signaling to prevent sustained cancer cell growth [45].